Skip to main content
Journal ArticleOPEN ACCESS

Regulation of YKL-40 expression by corticosteroids: Effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo

Respiratory Research (2015) 16(1)
DOI: 10.1186/s12931-015-0314-3
18Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Macrophages constitute a heterogeneous cell population with pro-(M1) and anti-inflammatory (M2) cells. The soluble chitinase-like-protein YKL-40 is expressed in macrophages and various other cell types, and has been linked to a variety of inflammatory diseases, including COPD. Dexamethasone strongly reduces YKL-40 expression in peripheral blood mononuclear cells (PBMC) in vitro. We hypothesized that: a) YKL-40 is differentially expressed by M1 and M2, b) is decreased by corticosteroids and c) that long-term treatment with inhaled corticosteroids (ICS) affects YKL-40 levels in serum and sputum of COPD patients. Methods: Monocytes of healthy subjects were cultured in vitro for 7 days with either GM-CSF or M-CSF (for M1 and M2, respectively) and stimulated for 24 h with LPS, TNFα, or oncostatin M (OSM). M1 and M2 differentiation was assessed by measuring secretion of IL-12p40 and IL-10, respectively. YKL-40 expression in macrophages was measured by quantitative RT-PCR (qPCR) and ELISA; serum and sputum YKL-40 levels were analyzed by ELISA. Results: Pro-inflammatory M1 cells secreted significantly more YKL-40 than M2, which was independent of stimulation with LPS, TNFα or OSM (p<0.001) and confirmed by qPCR. Dexamethasone dose-dependently and significantly inhibited YKL-40 protein and mRNA levels in M1. Serum YKL-40 levels of COPD patients were significantly higher than sputum YKL-40 levels but were not significantly changed by ICS treatment. Conclusions: YKL-40 secretion from M1 cells is higher than from M2 cells and is unaffected by further stimulation with pro-inflammatory agents. Furthermore, YKL-40 release from cultured monocyte-derived macrophages is inhibited by dexamethasone especially in M1, but ICS treatment did not change YKL-40 serum and sputum levels in COPD. These results indicate that YKL-40 expression could be used as a marker for M1 macrophages in vitro, but not for monitoring the effect of ICS in COPD. Trial registration: ClinicalTrials.gov, registration number: NCT00158847

Figures

  • Fig. 1 Characterization of differentiated MΦ1 and MΦ2. a: IL-12p40 (left panel) and IL-10 (right panel) in supernatants of MΦ1 and MΦ2, respectively, stimulated with LPS for 24 h. Data represent means with SEM of 6 donors, ** p < 0.01 or *** p < 0.001 between MΦ1 and MΦ2. b: Flow cytometry analysis for CD68, CD14 and CD163 (left, middle and right panel, respectively) for MΦ1 and MΦ2 (upper and lower panel, respectively)
  • Table 1 Primer pairs used for quantitative reverse-transcriptase polymerase chain reaction (qPCR)
  • Fig. 2 MΦ1 produce more YKL-40 compared to MΦ2. a: YKL-40 secretion measured by ELISA (left panel, 6 donors) and mRNA levels (normalized expression, right panel, 5 donors) in MΦ1 and MΦ2 after medium and LPS stimulation for 24 h. * p < 0.05 or *** p < 0.001 between MΦ1 and MΦ2. b: Flow cytometry analysis of MΦ1 and MΦ2 with and without anti-YKL-40 and secondary antibody. Left panel: MΦ1 with secondary antibody (purple) and MΦ1 with anti-YKL-40 and secondary antibody (black); middle panel: MΦ2 with secondary antibody alone (purple) and MΦ2 with anti-YKL-40 and secondary antibody (black); right panel: MΦ1 and anti-YKL-40 with secondary antibody (red) and MΦ2 and anti-YKL-40 with secondary antibody (blue). c: YKL-40 secretion in MΦ1 and MΦ2 after 24 and 48 h of stimulation with medium, LPS, TNFα and oncostatin M (OSM). Data represent mean and SEM of 4 and 3 donors (24 and 48 h, respectively). *: p < 0.001 between MΦ1 and MΦ2 for corresponding stimulus and time. $: p < 0.001 between corresponding stimulus at different time points. d: Immunofluorescence staining on sputum cytospin of a COPD patient (blue: DAPI; red: YKL-40; green: CD68)
  • Fig. 3 IL-12p40 secretion is dose-dependently inhibited by dexamethasone when added on day 0. IL-10 and IL-12p40 secretion with addition of dexamethasone at day 0, 3 and 7 of differentiation (0.1, 0.3 and 1nM) (a and b, left, middle and right panel, respectively). Data represent means and SEM (n = 3 donors). * p≤ 0.05, ** p < 0.01 or *** p < 0.001: between MΦ1 to MΦ2 with corresponding stimulus. $ p ≤ 0.05 or $ p < 0.001 between MΦ1 at different concentrations of dexamethasone
  • Fig. 4 YKL-40 expression and protein secretion is inhibited by dexamethasone. YKL-40 mRNA levels (normalized expression) and YKL-40 protein secretion (a and b, respectively) in MΦ1 and MΦ2 with addition of dexamethasone at day 0, 3 and 7 of differentiation (0.1, 0.3 and 1nM) (left, middle and right panel, respectively). LL-37 mRNA levels (normalized expression) after 0, 3 and 7 days of differentiation with dexamethasone (0.1, 0.3 and 1nM) (c left, middle and right panel, respectively). Data represent means and SEM (n = 3 donors). * p≤ 0.05, ** p < 0.01 or *** p < 0.001 compared to MΦ2 with corresponding stimulus. $ = p≤ 0.05, $$ p < 0.01 or $$$ p < 0.001 compared to corresponding unstimulated cells. ##: p < 0.01 or ### p < 0.001 compared to corresponding LPS stimulated cells
  • Fig. 5 YKL-40 protein secretion and mRNA expression is inhibited by the demethylating agent 5AZA. IL-10 and IL-12p40 secretion after stimulation with 5-AZA (concentration 0.1, 1 and 10 μM) (a and b, respectively). YKL-40 protein secretion and mRNA expression in MΦ1 and MΦ2 after culturing with 5-AZA (concentration 0.1, 0.3 and 1nM) (c and d, respectively). Differentiated cells are stimulated with 100 ng/ml LPS for 24 h. Data represent mean and SEM (n = 3 donors). * p≤ 0.05, ** p < 0.01 or *** p < 0.001 compared to MΦ2 with corresponding stimulus. # p≤ 0.05, ##: p < 0.01 or ### p < 0.001 compared to corresponding LPS stimulated cells
  • Table 2 Patient characteristics of compliant patients at baseline of the GLUCOLD study
  • Fig. 6 Sputum and serum YKL-40 protein levels of COPD patients before and after ICS treatment. YKL-40 levels in sputum and serum at baseline (0) and after 30 months (30 m) of inhaled corticosteroids (ICS) and placebo. For comparison of the levels between baseline and 30 months, we only included patients from whom samples were available at both time points (paired data). Each dot represent a single patient, red horizontal bars represent medians

References Powered by Scopus

Macrophage plasticity and polarization: In vivo veritas

Journal of Clinical Investigation
4938Citations
N/AReaders
Get full text

Monocyte and macrophage heterogeneity

Nature Reviews Immunology
4213Citations
N/AReaders
Get full text

Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury

Annual Review of Physiology
698Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
163Citations
N/AReaders
Get full text

Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases

Pharmacology and Therapeutics
96Citations
N/AReaders
Get full text

Conceptual advances and evolving terminology in acute kidney disease

Nature Reviews Nephrology
57Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kunz, L. I. Z., van’t Wout, E. F. A., van Schadewijk, A., Postma, D. S., Kerstjens, H. A. M., Sterk, P. J., & Hiemstra, P. S. (2015). Regulation of YKL-40 expression by corticosteroids: Effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo. Respiratory Research, 16(1). https://doi.org/10.1186/s12931-015-0314-3

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 23

70%

Researcher 5

15%

Professor / Associate Prof. 4

12%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

48%

Biochemistry, Genetics and Molecular Bi... 8

24%

Agricultural and Biological Sciences 5

15%

Pharmacology, Toxicology and Pharmaceut... 4

12%

Save time finding and organizing research with Mendeley

Sign up for free
0